| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| LENSAR, Inc. | Director | Common Stock | 49,947 | $693,763 | $13.89 | 23 May 2025 | Direct |
| GERON CORP | Director | Stock Option (right to buy) | 180,000 | 21 May 2025 | Direct | ||
| Inhibikase Therapeutics, Inc. | Director | Stock Option (right to buy) | 40,000 | 24 Jun 2022 | Direct | ||
| SpyGlass Pharma, Inc. | Director | Stock Option (right to buy) | 13,700 | 05 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 1 | $0 | 4 | Director | 09 Feb 2026, 16:46 |
| SGP | SpyGlass Pharma, Inc. | 05 Feb 2026 | 0 | $0 | 3 | Director | 05 Feb 2026, 13:07 |
| LNSR | LENSAR, Inc. | 23 May 2025 | 1 | $0 | 4 | Director | 28 May 2025, 16:30 |
| GERN | GERON CORP | 21 May 2025 | 1 | $0 | 4 | Director | 22 May 2025, 17:01 |
| GERN | GERON CORP | 09 May 2024 | 1 | $0 | 4 | Director | 10 May 2024, 16:05 |
| LNSR | LENSAR, Inc. | 07 May 2024 | 1 | $0 | 4 | Director | 09 May 2024, 16:30 |
| GERN | GERON CORP | 24 Aug 2023 | 2 | +$30,064 | 4 | Director | 24 Aug 2023, 20:52 |
| GERN | GERON CORP | 31 May 2023 | 1 | $0 | 4 | Director | 02 Jun 2023, 19:35 |
| LNSR | LENSAR, Inc. | 25 May 2023 | 2 | $0 | 4 | Director | 30 May 2023, 17:01 |
| IKT | Inhibikase Therapeutics, Inc. | 24 Jun 2022 | 1 | $0 | 4 | Director | 28 Jun 2022, 21:00 |
| LNSR | LENSAR, Inc. | 25 May 2022 | 2 | $0 | 4 | Director | 27 May 2022, 21:24 |
| GERN | GERON CORP | 10 May 2022 | 1 | $0 | 4 | Director | 11 May 2022, 18:17 |
| IKT | Inhibikase Therapeutics, Inc. | 25 Jun 2021 | 1 | $0 | 4 | Director | 29 Jun 2021, 19:12 |
| LNSR | LENSAR, Inc. | 18 May 2021 | 1 | $0 | 4 | Director | 20 May 2021, 16:15 |
| GERN | GERON CORP | 11 May 2021 | 1 | $0 | 4 | Director | 13 May 2021, 21:25 |